# Akari Therapeutics Plc: Form SC 13D/A, filed Dec 6, 2024

- Company: [Akari Therapeutics Plc](/companies/aktx.md) (CIK 1541157)
- Form: SC 13D/A
- Filed: 2024-12-06
- Accepted by EDGAR: Dec 6, 2024, 16:00 ET
- Period: not reported
- Accession: 0001213900-24-106465
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1541157/000121390024106465/ea0223686-13da1patel_akari.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1541157/000121390024106465/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1541157/000121390024106465/ea0223686-13da1patel_akari.htm

Filed Dec 6, 2024.
Source: SEC EDGAR, the filing index for accession 0001213900-24-106465. Last ingested by Listed: Oct 30, 2026, 17:09 ET. No prices; not investment advice.